KRISTINA WAGNER: Open Payments
NPI 1528610466 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 61 payments from 15 companies in 2025. Trend: 2023 $838 · 2024 $2,046 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $463 |
| HEARTFLOW, INC. | 2 | $167 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| E.R. Squibb & Sons, L.L.C. | 9 | $160 |
| ABIOMED | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $91 |
| PFIZER INC. | 2 | $40 |
| BridgeBio Pharma, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $31 |
Products named: LEQVIO, FFRct, CAMZYOS, JARDIANCE, LifeVest, WAINUA, FARXIGA, ELIQUIS.
Industry payments across GA — which companies pay providers there.
